0001213900-23-012598.txt : 20230217 0001213900-23-012598.hdr.sgml : 20230217 20230217083007 ACCESSION NUMBER: 0001213900-23-012598 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kapoor Vishal CENTRAL INDEX KEY: 0001798946 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39138 FILM NUMBER: 23640394 MAIL ADDRESS: STREET 1: 1177 AVENUE OF THE AMERICAS, FL 40 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jasper Therapeutics, Inc. CENTRAL INDEX KEY: 0001788028 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842984849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 6505491400 MAIL ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp DATE OF NAME CHANGE: 20190912 4 1 ownership.xml X0306 4 2023-02-16 0 0001788028 Jasper Therapeutics, Inc. JSPR 0001798946 Kapoor Vishal C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PKWY, SUITE 102 REDWOOD CITY CA 94065 1 0 0 0 Stock Option (right to buy) 1.83 2023-02-16 4 A 0 109383 0.00 A 2033-02-16 Voting Common stock 109383 109383 D 1/3rd of the shares subject to the option shall vest on February 16, 2024, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. /s/ Jeet Mahal, as Attorney-in-Fact 2023-02-17